EF
SRPT icon

Empowered Funds’s Sarepta Therapeutics SRPT Stock Holding History

Empowered Funds’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Buy
190,586
+76,651
+67% +$1.45M 0.02% 892
2026
Q1 		$2.48M Buy
+113,935
New +$2.21M 0.02% 987
2024
Q1 		– Sell
-9,241
Closed -$891K – 1437
2023
Q4 		$891K Buy
+9,241
New +$886K 0.02% 806
2023
Q2 		– Sell
-22,257
Closed -$3.07M – 1177
2023
Q1 		$3.07M Buy
+22,257
New +$2.89M 0.18% 153
2018
Q3 		– Sell
-16,835
Closed -$2.25M – 117
2018
Q2 		$2.25M Sell
16,835
-2,094
-11% -$197K 0.71% 45
2018
Q1 		$1.36M Buy
+18,929
New +$1.26M 0.5% 46

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Empowered Funds's SRPT Position: Q2 2026 in Review

Empowered Funds increased its Sarepta Therapeutics (SRPT) stake by 67% in Q2 2026, buying an estimated $1.45M and bringing the position to 190,586 shares worth $3.42M. The position accounts for 0.02% of the portfolio, ranked #892.

Empowered Funds first reported a position in SRPT in Q1 2018 and has held it in 6 quarters since. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Empowered Funds held 190,586 shares of Sarepta Therapeutics worth $3.42M as of Q2 2026.
  • Empowered Funds bought 76,651 Sarepta Therapeutics shares in Q2 2026, an estimated $1.45M.
  • Sarepta Therapeutics made up 0.02% of Empowered Funds's portfolio in Q2 2026, its #892 holding.
  • Empowered Funds first reported a position in Sarepta Therapeutics in Q1 2018 and has held it in 6 quarters since.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.